David F Archer. Show Affiliations »
Abstract
Entities: Chemical Species
Mesh： See more » Breast Neoplasms/epidemiologyEstrogen Antagonists/adverse effectsEstrogen Antagonists/therapeutic useEstrogens/agonistsFemaleFemale Urogenital Diseases/chemically inducedFemale Urogenital Diseases/epidemiologyHumansIndoles/adverse effectsIndoles/therapeutic useOsteoporosis, Postmenopausal/drug therapyPostmenopause/drug effectsPyrrolidines/adverse effectsPyrrolidines/therapeutic useRaloxifene Hydrochloride/adverse effectsRaloxifene Hydrochloride/therapeutic useReceptors, EstrogenSelective Estrogen Receptor Modulators/adverse effectsSelective Estrogen Receptor Modulators/therapeutic useTamoxifen/adverse effectsTamoxifen/therapeutic useTetrahydronaphthalenes/adverse effectsTetrahydronaphthalenes/therapeutic use
Substances： See more » Estrogen AntagonistsEstrogensIndolesPyrrolidinesReceptors, EstrogenSelective Estrogen Receptor ModulatorsTetrahydronaphthalenesTamoxifenLasofoxifeneRaloxifene Hydrochloridebazedoxifene
Year: 2011 PMID： 21173718 DOI： 10.1097/gme.0b013e318203a46b
Source DB: PubMed Journal: Menopause ISSN： 1072-3714 Impact factor: 2.953